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Background: Increased life expectancy has resulted in a greater provision of informal care within the community
for patients with chronic physical health conditions. Informal carers are at greater risk of poor mental health, with
one in three informal carers of stroke survivors experiencing depression. However, currently no psychological
treatments tailored to the unique needs of depressed informal carers of stroke survivors exist. Furthermore, informal
carers of stroke survivors experience a number of barriers to attending traditional face-to-face psychological services,
such as lack of time and the demands of the caring role. The increased flexibility associated with supported
cognitive behavioral therapy self-help (CBTsh), such as the ability for support to be provided by telephone, email, or
face-to-face, alongside shorter support sessions, may help overcome such barriers to access. CBTsh, tailored to
depressed informal carers of stroke survivors may represent an effective and acceptable solution.
Methods/Design: This study is a Phase II (feasibility) randomized controlled trial (RCT) following guidance in the MRC
Complex Interventions Research Methods Framework. We will randomize a sample of depressed informal carers of
stroke survivors to receive CBT self-help supported by mental health paraprofessionals, or treatment-as-usual.
Consistent with the objectives of assessing the feasibility of trial design and procedures for a potential larger scale trial
we will measure the following outcomes: a) feasibility of patient recruitment (recruitment and refusal rates); (b)
feasibility and acceptability of data collection procedures; (c) levels of attrition; (d) likely intervention effect size; (e)
variability in number, length and frequency of support sessions estimated to bring about recovery; and (f) acceptability
of the intervention. Additionally, we will collect data on the diagnosis of depression, symptoms of depression and
anxiety, functional impairment, carer burden, quality of life, and stroke survivor mobility skill, self-care and functional
ability, measured at four and six months post-randomization.
Discussion: This study will provide important information for the feasibility and design of a Phase III (effectiveness) trial
in the future. If the intervention is identified to be feasible, effective, and acceptable, a written CBTsh intervention for
informal carers of stroke survivors, supported by mental health paraprofessionals, could represent a cost-effective model
of care.
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Technological advances in healthcare have resulted in in-
creased life expectancy across the developed world [1].
However, such increases have led to significant challenges,
with excessive demand placed upon the provision of treat-
ment and care of patients with chronic physical health
conditions [1,2]. This has resulted in an increased reliance
on informal care within the community for people with
chronic physical health conditions [3]. However, increased
provision of informal care places informal carers at greater
risk of poor mental and physical health [4-6] accompanied
by reduced opportunity for paid employment and social
activity [7]. On average, 30% of informal carers experience
depression [8]. Rates are even higher when the chronic
physical health condition causes significant behavioral,
cognitive, and emotional impairment in the patient being
cared for [9]. Significant forms of impairment are experi-
enced with stroke [10], with 30 to 68% of informal carers
of stroke survivors experiencing depression from the time
of the initial stroke to three years post-stroke [11,12].
Given such a high prevalence of depression, demand for
accessible evidence-based psychological interventions tar-
geted at informal carers of stroke survivors is high.
Although evidence-based psychological treatments for
depression exist [13] the costs of service delivery are
high, with demand for treatment exceeding the capacity
of therapists, resulting in long waiting lists [14] and lim-
ited access [15]. Additionally, informal carers experience
specific barriers to accessing primary care services [16].
Barriers have included a lack of recognition of the diffi-
culties associated with the caring role by health profes-
sionals [16], with general practitioners more likely to
provide practical support rather than referral for formal
psychological treatment. Additionally, interventions are
predominantly focused on the stroke survivor rather
than the informal carer [17,18]. The longterm psycho-
logical needs of informal carers of stroke survivors have
therefore been largely neglected, making it difficult for
informal carers to access evidence-based psychological
therapies [19-21].
To improve access to evidence-based psychological
therapies, there have been movements towards the use of
supported cognitive behavioral therapy self-help (CBTsh)
for the treatment of mild to moderate depression and anx-
iety disorders [22]. Meta-analyses of supported CBTsh
provide evidence that it is an efficacious treatment for de-
pression and anxiety [23-26]. Furthermore, when com-
pared with traditional CBT no significant difference in
overall effect size was found, suggesting supported CBTsh
and traditional CBT are comparable treatments for both
depression and anxiety [27]. CBTsh is not delivered by a
therapist, rather CBT specific principles are communi-
cated to the patient through the use of self-help materials,
commonly in a written or internet-based format [22].Guidance and motivation appear to increase effectiveness
[24] although the need for support differs across mental
health conditions [25]. To further increase access, support
is provided in a variety of ways including telephone, email,
or face-to-face [22]. Because the demands of caring are
often a barrier to attending therapy [16,28], the increased
flexibility associated with the delivery of CBTsh may in-
crease access to appropriate psychological support for in-
formal carers of stroke patients.
Although CBTsh interventions are available for de-
pression, evidence highlights that significant adaptations
to interventions may be required prior to application to
different depressed populations, for example, to those
with depression co-morbid to a physical health condition
[29]. Additionally, although CBTsh appears effective for
common mental health difficulties, reviews of CBTsh in-
terventions for people with physical health conditions
are less promising [30-32]. This raises the possibility that
benefits demonstrated in general CBTsh interventions
for adult depression may not generalize to medical pop-
ulations that have depression as a secondary comorbidity
or informal carers of people with physical health condi-
tions. Indeed, mental health services for carers have
been criticized for not being tailored to address the
unique difficulties informal carers experience [33]. Such
difficulties include informal carers managing behavioral
problems [34], physical impairments [34] and cognitive
impairment [35], all of which are experienced by infor-
mal carers of stroke survivors [9]. To the best of our
knowledge, only three published studies have examined
CBTsh for depression within informal carer populations,
specifically carers of people with anorexia nervosa
[36,37] and cancer patients [38]. It is therefore clear that
more research is required into both the effectiveness and
acceptability of CBTsh interventions for the treatment of
depression in informal carers of patients with chronic
physical health conditions.
Over the last decade there has been a growing recog-
nition of the importance of understanding patients’ ex-
periences when developing health resources [39,40] and
healthcare policy [41]. Reflecting this recommendation,
a new written CBTsh self-help intervention has been de-
veloped specifically targeted at depressed informal carers
of stroke survivors [42]. The content was informed
through a series of qualitative studies to understand the
specific difficulties and challenges experienced by de-
pressed informal carers of stroke survivors, and helpful
coping strategies used by currently non-depressed infor-
mal carers. The new CBTsh intervention recognizes and
targets the difficulties commonly experienced by infor-
mal carers of stroke survivors identified through the
qualitative studies. Additionally, helpful coping strategies
used by currently non-depressed informal carers were
used to further inform and adapt the content of written
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provide a useful aid to informal carers experiencing
emotional difficulties [43]. This study seeks to examine
the feasibility of running a definitive randomized con-
trolled trial (RCT) to examine the effectiveness accept-
ability of this specially adapted CBTsh intervention.
Study aims and objectives
We will conduct a feasibility phase II RCT [44,45] compar-
ing a written CBTsh intervention for depressed informal
carers of stroke survivors supported by paraprofessional
mental health workers (Psychological Wellbeing Practi-
tioners; PWPs) with treatment-as-usual (TAU). Outcomes
will assess a number of methodological and procedural un-
certainties that require investigation prior to designing and
applying for funding for a Phase III trial. Therefore the fol-
lowing four questions will be addressedFor informal carers
of stroke survivors receiving CBTsh in a fully powered
phase III trial, what would be the estimates of likely recruit-
ment and retention rate; estimates of the range of effect
sizes; feasibility and acceptability of data collection methods
and instruments; and acceptability and structure of the
treatment procedures to participants?
Methods/Design
Study design
We will conduct a single blind parallel group feasibility
RCT comparing CBTsh for depressed informal carers of
stroke survivors (intervention group) with TAU (control
group). This protocol follows CONSORT [46] and SPIRIT
[47] guidelines for reporting clinical trial protocols.
Setting
We will recruit participants over a six-month period
through primary care services, specialist stroke healthcare
settings, and community organizations in the counties of
Cornwall and Dorset (southwest England). Participants
will be treated within primary care mental health services
commissioned under the Improving Access to Psycho-
logical Therapies program (IAPT) [48].
Participant inclusion criteria
Eligible participants will be self-identified informal carers
of stroke survivors at a minimum of two months post-
home discharge (relating to the time of the most recent
stroke), aged 16 and over. We will recruit participants
meeting the 10th revision of the International Statistical
Classification of Diseases and Related Health Problems
(ICD-10) criteria for major depression as determined by
the Clinical Interview Schedule (CIS-R) [49] and who
score between 10 and 22 on the Patient Health
Questionnaire-9 (PHQ-9) [50]. To reflect standard prac-
tice participants will be eligible to participate in the
study whether or not they are currently receivingantidepressant medication, however the dose must have
been stable for at least one month prior to recruitment
into the study. All participants need to be able to read in
English in order to engage with the written CBTsh
intervention.
Participant exclusion criteria
Potential participants with post-traumatic stress disorder
(PTSD), psychosis, bipolar disorder, current substance or
alcohol abuse, or who are acutely suicidal will be excluded
from participation in the study, in addition to those cur-
rently receiving formal psychotherapy for their depression.
Recruitment settings and procedure
A number of recruitment techniques will be utilized in-
cluding letter mail-out, the use of brochures, posters
and flyers, advertisement in newsletters, and direct refer-
ral from healthcare professionals. Such multifaceted re-
cruitment techniques have been successfully used to
recruit informal carers of people with dementia [51]. De-
tails of the recruitment strategies to be used within each
recruitment setting are detailed below.
Primary care
Participants will be recruited by searching GP records, a
strategy successfully employed within other depression
trials [52-54]. First, practice staff will search general
practice electronic case records for stroke survivors.
Practice staff will subsequently manually screen these re-
cords to identify stroke survivors who have a known in-
formal carer. Practice staff will send a study invitation
pack to all identified informal carers inviting them to
take part, including an invitation letter, patient informa-
tion sheet, and reply slip. Informal carers will reply dir-
ectly to the research team to express whether they
would like to be contacted to discuss the research in
more detail either by using the reply slip or calling the
research team directly. Additionally, GPs will be able to
directly refer suitable informal carers to the study team
and study posters will be displayed in practice reception
rooms to further advertise the study.
Specialist stroke care settings
We will also recruit participants from clinical acute and
community based stroke healthcare settings, for example
acute stroke units, stroke rehabilitation units, community
early discharge, and rehabilitation teams. Stroke research
nurses and community stroke healthcare professionals will
approach informal carers seen within these settings and
provide brief details about the study and a study invitation
pack. If interested, informal carers can either consent for
their contact details to be sent to the research team or
reply directly to the research team themselves.
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Participants will also be recruited through a variety of
community based stroke and informal carer charities
such as the Stroke Association, Different Strokes, and
community stroke clubs and groups. Groups and char-
ities interested in supporting the study will be provided
with brochures and flyers advertising the study to hand
out to informal carers. The research team will also en-
deavor to give presentations to members of stroke and
informal carer groups to further advertise the research
program. Additionally, the study will be advertised in
stroke and informal carer charity newsletters.
Reasons for non-participation
All study invitation packs will also include anonymized
reply slips with space for writing reasons for non-
participation and researchers will ask participants for
reasons from those who verbally decline. It will be
made clear that researchers will not be trying to per-
suade participants to reconsider their decision. This in-
formation will provide further information in terms of
the feasibility of recruitment and acceptability of the
intervention.
Screening, baseline and informed consent
A researcher will speak to all informal carers of stroke
survivors about the study in more detail. If interested in
participating in the study, informal carers will be asked
to provide verbal consent for a telephone screen to be
conducted against the inclusion criteria to confirm the
current level of depressive symptoms, length of time car-
ing, and any history of PTSD, psychosis, bipolar disorder,
and current substance or alcohol abuse. If eligible to
participate, dependent upon preference, the potential
participant will be invited to attend a full screening ap-
pointment via the telephone or face-to-face, to confirm
a diagnosis of major depression using the CIS-R. If eli-
gible, the full baseline assessment will be undertaken.
Potential participants will be required to provide full
written informed consent before the full screening ap-
pointment or baseline can take place. Once the full base-
line assessment has taken place, participants will be
randomized (see Figure 1).
Randomization and allocation concealment
We will randomly allocate eligible participants to one of
the two study arms - supported CBTsh or TAU - using a
web-based randomization service at the Peninsula Clinical
Trials Unit which will be concealed from the research
team. We will use minimization to ensure balance be-
tween arms in relation to site in order to assist with
efficient study management (East Dorset, West Dorset,
North Cornwall, and South Cornwall) and factors that
may affect the outcomes: PHQ-9 score (Moderate: PHQ-9score 10 to 14; Moderately Severe: PHQ-9 score 15 to 22)
and sex (male or female). The minimization algorithm
will contain a stochastic element to maintain a degree of
unpredictability when allocating. In order to preserve
the blinding of research personnel participants will be
informed as to which study arm they have been allo-
cated by a researcher not otherwise associated with the
study.
Sample size
No formal power calculations are usually undertaken in
feasibility RCTs [55]. Instead a sufficient sample size to
calculate the critical parameters relating to the feasibility
outcomes in the trial, for example recruitment and attri-
tion rates [55], should be used. As such, we will use the
recommended sample size of 30 participants per arm for
feasibility studies [56] consistent with the median sample
size found in both feasibility and pilot RCTs [57]. This
will provide a reasonable indication of the likely sample
size required for a larger trial [45,58].
Treatments
Intervention
Participants will receive one assessment session and up
to twelve support sessions. Limiting the number of ses-
sions used to support the intervention is identified as
one of the characteristics associated with low-intensity
CBT [59]. The number of support sessions received will
be decided collaboratively between the PWP and partici-
pant. The initial assessment session will be of 35 minutes
duration, with subsequent sessions lasting between 25
and 35 minutes each. During their first assessment ses-
sion participants will receive the CBTsh introduction
workbook specifically developed for the trial [42]. The
assessment session will mainly comprise a client-
centered assessment to understand the difficulties expe-
rienced by the participant alongside the provision of
information concerning the impact of depression, the
impact of the caring role on mood, and the CBT ap-
proach. Participants will also be provided with more in-
formation about each of the three possible interventions
(behavioral activation, problem solving, and goal setting)
by the PWP, supplemented by the introduction work-
book [42]. During the first support session participants
will be provided with an additional workbook detailing
the particular CBTsh intervention they wish to use (be-
havioral activation, problem solving, or goal setting).
Subsequent support sessions will provide guidance and
encouragement around the use of the chosen CBTsh
intervention. All assessment and support sessions will
follow a structured treatment support protocol [60]
adapted to fit the needs of carers that were identified
within the treatment development phase. Assessment
and support sessions will be provided either face-to-face,
6 month post-randomisation
follow-up
Analysed n = 
Lost to follow-up n =
Withdrew n =
Not contactable n =
Other n =
Post-treatment follow-up (4
months)
Analysed n = 
Lost to follow-up n =
Withdrew n =
Not contactable n =
Other n =
Allocated to CBTsh n =
Received allocated intervention n =
Post-treatment follow-up( 4
months)
Analysed n = 
Lost to follow-up n =
Withdrew n =
Not contactable n =
Other n =
Allocated to TAU n =
Received allocated intervention n =
6 month post-randomisation
follow-up Analysed n =
Lost to follow-up n =
Withdrew n =
Not contactable n =
Other n =
Allocation
Analysis
Follow-Up
Assessed for eligibility n=
Excluded n = 
Did not meet inclusion criteria: 
Not depressed or anxious n = 
Age < 16 years n = 
Receiving psychological therapy 
n = 
History of psychosis or bipolar 
disorder n =  
Drug or alcohol misuse n =
Other n =
Randomised n =
Enrollment
Figure 1 CONSORT diagram.
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methods as determined by participants’ preference. All
participants will receive relapse prevention during their
final support session, again guided by a relapse preven-
tion workbook developed for the study.
Those providing support will be qualified PWPs trained
in accordance with the curriculum supporting the Im-
proving Access to Psychological Therapies Programme
[61,62] to deliver low-intensity CBT-based interventions
for depression and anxiety [63]. PWPs will also receive an
additional one day training session delivered by the first
author, alongside a carer of a stroke survivor and a stroke
healthcare professional. Consistent with IAPT supervision
guidance for the PWP workforce [64] PWPs will be pro-
vided with weekly case management supervision to pro-
vide advice and support by an experienced mental health
professional within the service. Case management super-
vision will be delivered to predetermined protocolsensuring all participants are brought to supervision at pre-
set times during treatment or when they display particular
clinical characteristics and risk [63]. PWPs supporting the
intervention will also be provided with group clinical
supervision by an IAPT clinical educator once a month.
This supervision will focus on the discussion of cases and
ongoing clinical skills development, will last approxi-
mately 45 minutes, and be provided for the duration of
the treatment phase of the trial.Control - treatment-as-usual
Participants randomized to the control condition will re-
ceive usual care delivered by their general practitioner or
other healthcare provider. In general, this may include a
consultation with their general practitioner, the prescrip-
tion of antidepressant medication, or a referral to a men-
tal health service for psychological intervention.
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The study is single blind, with the research staff con-
ducting outcome assessment interviews remaining blind
to group allocation. Participants will be reminded not to
disclose the arm they have been randomized to during
contact with the researcher throughout the duration of
the trial. To maintain blinding of the outcome assessor,
acceptability interviews will be conducted by a re-
searcher not otherwise associated with the study. Due to
the nature of the intervention, participant and clinician
blinding is not possible.
Outcome measurements
Feasibility outcome measurements
The feasibility of participant recruitment will be exam-
ined including numbers assessed for eligibility; numbers
eligible; reasons for ineligibility; reasons for non-
participation and numbers randomized. Additionally
comparisons will be made between recruitment settings
and recruitment techniques.
The relative levels of diagnosis of depression between
treatment arms at post-treatment (four months) will be
determined using the CIS-R.
The feasibility and acceptability of data collection pro-
cesses will be investigated through the number of miss-
ing items and follow -up rates relating to the clinical
outcome measurements likely to be used in a Phase III
trial. Additionally, we will examine levels of attrition
through treatment and study drop-out rates.
The range of number, length, and frequency of support
sessions required to bring about recovery from depres-
sion, defined as a score of ≤9 on the PHQ-9, as per
current IAPT guidance [65] will also be reported.
The acceptability of the treatment will be examined
through reasons reported for not attending support ses-
sions, reasons for withdrawal from treatment and ac-
ceptability interviews will be conducted at four months
post-randomization.
PWP adherence to the protocol will be examined
using audio tapes of treatment sessions. Levels of PWP
adherence to the protocol will be judged by a member of
academic staff involved in delivering PWP training on
an accredited PWP training programme. A randomly se-
lected sample of 20% recorded treatment sessions for
each PWP in the study will be assessed for levels of
adherence.
Clinical outcome measurements
A number of clinical outcome measurements have been
included to examine the feasibility of the proposed data
collection process, estimates of relative levels of diagnosis
of depression between arms at post-treatment and the
range of number, length, and frequency of support ses-
sions required to bring about recovery from depression.The CIS-R will be used to assess diagnosis of depression
and the PHQ-9 will be taken to measure depression se-
verity. Symptoms of anxiety will be measured using the
Generalized Anxiety Disorder 7-item Scale (GAD-7) [66]
and levels of functional impairment will be measured
using the Work and Social Adjustment Scale (WSAS]
[67]. Stroke survivors’ mobility skill and self-care will be
examined with the Barthel Activities of Daily Living Index
(BI) [68]. The measure will be completed by the informal
carer on behalf of the stroke survivor. Discrepancies arise
between stroke survivor and informal carer assessment of
stroke survivor functional ability, with carers rating pa-
tients as more disabled [69]. However, such disagreement
has been found to be associated with increased carer bur-
den [69] and is therefore of interest to collect. Stroke sur-
vivors’ level of functional impairment will be measured
through the Frenchay Activities Index (FAI) [70]. The
measure will be completed by the informal carer on behalf
of the stroke survivor. Due to bias found when using
proxy scores on the FAI [71] results will be interpreted
with caution. However the use of proxy measurements on
the FAI are considered suitable for research purposes [72].
Carer burden will be measured using the Caregiver Bur-
den Scale (CBS) [73]. We will also measure informal carer
quality of life using both the Short Form (36) Health Sur-
vey (SF-36) [74]; and the EuroQol-5D (EQ-5D) [75]. Fi-
nally, health and public service use will be collected using
an adapted version of the Client Socio-Demographic and
Service Receipt Inventory (CSRI) [76]. The version of the
CSRI for use in this study has been adapted from the ori-
ginal CSRI [76] and a further version developed for infor-
mal carers of stroke survivors [77].Demographics
Several background and socio-demographic variables
will be collected at screening for informal carers and
stroke survivors.
The collected variables for an informal carer: source of
referral; age; gender; ethnic background; relationship sta-
tus; relationship to stroke survivor; employment status;
yearly household outcome; highest level of academic
qualification; length of time caring; whether lives with
the stroke survivor; provision of care before the stroke;
receipt of support services in the home; hours of support
services received in the home per week, and hours of
caring per week.
The collected variables for a stroke survivor: age; gen-
der; ethnic background; relationship status; employment
status; date of first stroke; date of most recent stroke;
type of first stroke (ischemic, hemorrhage, transient is-
chemic attack (TIA)); type of most recent stroke, (ische-
mic, hemorrhage, TIA) and whether the stroke survivor
is aphasic.
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Dependent upon participant preference, the researcher
will collect data either over the telephone or face-to-face
at screening, baseline, four months and six months post-
randomization. The adapted CSRI will be collected via
post due to the potential for unblinding as the measure
includes information about the receipt of psychological
treatment. A summary of outcomes collected at each
time point can be seen in Table 1.
Acceptability of the intervention
Study objectives and design
We will conduct a sub study to examine the following
question: what are participants’ views on the acceptability
of CBTsh? Semi-structured interviews will be conducted
with all participants randomized to receive CBTsh to
examine the acceptability of the new intervention. Open-
ended questions will be asked around participants’
impressions of supported CBTsh; the relevance and suit-
ability of the intervention for carers and relatives of stroke
survivors; receiving support; specific interventions used;
perceived benefit and impact of the intervention; difficul-
ties experienced using the intervention; continued use of
self-help strategies; and recommendations for futureTable 1 Study clinical outcome measures by time point
Outcome measure Time point
Demographics
(informal carer)
Initial screen
Demographics
(stroke survivor)
Initial screen
PHQ-9 Initial screen; four months post-randomization;
six months post-randomization
GAD-7 Initial screen; four months post-randomization;
six months post-randomization
CIS-R Full screen; four months post-randomization;
six months post-randomization
WASAS Baseline; four months post-randomization;
six months post-randomization
CBS Baseline; four months post-randomization;
six months post-randomization
BI Baseline; four months post-randomization;
six months post-randomization
FAI Baseline; four months post-randomization;
six months post-randomization
SF-36 Baseline; four months post-randomization;
six months post-randomization
EQ-5D Baseline; four months post-randomization;
six months post-randomization
Health and public
service use
Baseline; four months post-randomization;
six months post-randomization
BI, Barthel activities of daily living index; CBS, Caregiver burden scale; CIS-R,
Clinical interview schedule; EQ-5D, EuroQol-5D; FAI, Frenchay activities index;
GAD-7, Generalized anxiety disorder 7-item scale; PHQ-9, Patient health
questionnaire-9; SF-36, Short form (36) health survey; WSAS, Work and social
adjustment scale.development. The topic guide has been partially informed
by a previous qualitative study investigating the accept-
ability of online-based CBTsh for depressed patients with
multiple sclerosis [29]. Non-attendees and poor attendees
will also be asked about reasons for dropping out of the
intervention and to consider what a more acceptable
intervention may look like. Interviews will be semi-
structured and conducted over the telephone. Interviews
are anticipated to last between 45 and 90 minutes, how-
ever the duration may be shorter for those categorized as
non-attendees and poor attendees.
Sampling
All participants allocated to receive the intervention will
be invited to participate. Dependent upon attendance of
support sessions, participants will be categorized into
one of the following: (i) non attendees, defined as not at-
tending any sessions; (ii) poor attendees, defined as at-
tending the assessment session and then terminating
treatment before reaching a shared decision with the
PWP to be discharged from treatment; or (iii) com-
pleters, defined as those who engage in treatment until a
shared decision is made with the PWP to terminate
treatment.
Statistical analysis
Quantitative
Data analysis will mainly be descriptive and address the
primary outcomes relating to the feasibility of conducting
a future definite RCT. Participant flow will be summarized
following the CONSORT diagram [46]. Recruitment and
attrition rates (both treatment and study dropouts) will be
calculated, along with 95% confidence intervals. Protocol
deviations, along with reasons and number of missing
items on questionnaires will be reported. The mean and
standard deviation for each outcome measurement will be
reported at baseline, four, and six months. The mean and
standard deviation will also be reported for the number,
length, and frequency of support sessions required to
bring about recovery.
Health economics
Estimates of cost-effectiveness will not be possible due
to the design reflecting a feasibility RCT. However the
feasibility and acceptability of collecting outcome meas-
urement relating to health-related quality of life and pa-
tient NHS and social support use will be examined.
Processes for estimating costs of delivering the interven-
tion will also be tested. The Short Form-6 dimension
(SF-6D) [78] will be used to gain measures of utility
from 11 items of the SF-36 covering 6 dimensions (phys-
ical functioning, social functioning, role limitations,
mental health, vitality, and pain). Both the SF-6D and
EQ-5D will be used to determine quality-adjusted life
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SF-6D and ceiling effects with the EQ-5D in different
study populations [79]. In addition, although both the
SF-36 and EQ-5D appear to respond to changes in de-
pression, the agreement between utility changes is low
[80]. These procedures will inform the economic evalu-
ation plan for the design of a future phase III RCT.
Qualitative
The five-stage framework approach [81] will be used to
analyze the verbatim notes and transcribed digital record-
ings from the interviews. Trustworthiness of the analysis
will be established by the use of triangulation by observa-
tion, whereby completed analyses conducted by JW will
be sent to one other researcher and a member of the lay
steering committee to discuss whether the analysis reflects
the generated themes [82]. Once the second analysis is
complete participants will be sent a summary of the find-
ings to confirm whether the analysis represents accurately
their experiences of the intervention [82].
Ethical approval
We will conduct the trial in accordance with the Helsinki
Declaration to safeguard the welfare and rights of partici-
pants. Ethical approval was received by the National
Research Ethics Committee South West for Cornwall and
Plymouth on 24 May 2013. REC Reference number: 13/
SW/0018. The Data Protection Act will be followed at all
times with all data securely stored and anonymized.
Discussion
This feasibility RCT has been designed to explore im-
portant feasibility questions that can be used to inform
the design and funding application of a possible future
definitive (Phase III) RCT. Furthermore, detailed explor-
ation of the acceptability of the new CBTsh intervention
will inform future treatment iterations.
A supported CBTsh intervention, tailored to the needs
of informal carers of stroke survivors, may represent an ef-
fective and accessible psychological intervention for de-
pression. As well as improving mood, supported CBTsh
may also improve informal carers’ quality of life and re-
duce carer strain and burden. Furthermore, improvements
in carer depression may also improve recovery outcomes
in stroke survivors themselves and represent a cost-
effective model of care both nationally and internationally.
Trial status
Recruitment commenced in September 2013 and is
ongoing.
Abbreviations
BI: Barthel activities of daily living index; CBS: Caregiver burden scale;
CBTsh: Cognitive-behavioral therapy self-help; CIS-R: Clinical interview
schedule; CONSORT: Consolidated standards of reporting trials; CSRI: Clientsocio-demographic and service receipt inventory; EQ-5D: EuroQol-5D;
FAI: Frenchay activities index; GAD-7: Generalized anxiety disorder 7-item
scale; GP: General practice; IAPT: Improving access to psychological therapies
program; ICD-10: International classification of diseases-10; MRC: Medical
research council; NHS: National health service; PHQ-9: Patient health
questionnaire-9; PTSD: Post-traumatic stress disorder; PWP: Psychological
wellbeing practitioner; QALY: Quality-adjusted life-year; RCT: Randomized
controlled trial; SF-36: Short form (36) health survey; SF-6D: The short form-6
dimension; TAU: Treatment-as-usual; WSAS: Work and social adjustment
scale.
Competing interests
The authors declare they have no competing interests.
Authors’ contributions
JW: conception, design, data collection, manuscript writing and final
approval of the manuscript. PF: conception, design, manuscript writing and
final approval of the manuscript. EW: critical revision and final approval of
the manuscript. DR: critical revision and final approval of the manuscript. DL:
critical revision and final approval of the manuscript. All authors have
approved the final manuscript.
Acknowledgements
This work was supported by The Dunhill Medical Trust [grant number:
RTF43/1111]. This study is also supported by Western Comprehensive Local
Research Network, the Primary Care Research Network and the Stroke
Research Network. We are grateful to: Celia Bouquet, David Cooper and
Hilary Cooper (Lay Steering Committee); Jules Jeffreys, Stroke Support Team
Lead, Royal Devon and Exeter NHS Foundation Trust (assisting with PWP
training); Kathryn Rayson, University of Exeter (PWP clinical supervisor); Sam
Gerdes, Vania Goldberger-Holland, Angela Mason, Ceri Summers, Dudley
Poole (trial PWPs); Lorna Cook (PhD student assisting with randomization)
and Hannah Gow (voluntary research assistant). We are also grateful for the
support provided by Dorset Healthcare University Foundation Trust and
Outlook Southwest.
Author details
1Mood Disorders Centre, Psychology, College of Life and Environmental
Sciences, University of Exeter, Perry Road, Exeter EX4 4QG, UK. 2Institute of
Health Research, University of Exeter Medical School, Heavitree Road, Exeter
EX1 2 LU, UK. 3Epidemiology and Public Health Group, University of Exeter
Medical School, Heavitree Road, Exeter EX1 2 LU, UK.
Received: 23 March 2014 Accepted: 15 April 2014
Published: 6 May 2014
References
1. Christensen K, Doblhammer G, Rau R, Vaupel JW: Ageing populations: the
challenges ahead. Lancet 2009, 374:1196–1208.
2. Lubitz J, Cai L, Kramarow E, Lentzner H: Health, life expectancy, and health
care spending among the elderly. N Engl J Med 2003, 349:1048–1055.
3. Wakefield BJ, Hayes J, Boren SA, Pak Y, Davis JW: Strain and satisfaction in
caregivers of veterans with chronic illness. Res Nurs Health 2012, 35:55–69.
4. Pinquart M, Sörensen S: Differences between caregivers and
noncaregivers in psychological health and physical health:
a meta-analysis. Psychol Aging 2003, 18:250–267.
5. Coe NB, van Houtven CH: Caring for mom and neglecting yourself? The
health effects of caring for an elderly parent. Health Econ 2009,
18:991–1010.
6. Canniscio CC, Jones C, Kawachi I, Colditz GA, Berkman L, Rimm E:
Reverberations of family illness: a longitudinal assessment of informal
caregiving and mental health status in the nurses’ health study.
Am J Public Health 2002, 92:1305–1311.
7. Salva J, Almeida DM, Davey A, Zarit SH: Routine assistance to parents:
effects on daily mood and other stressors. J Gerontol B Psychol Sci Soc Sci
2008, 63:S154–S161.
8. Davies B: The reform of community and long-term care of elderly
persons: an international perspective. In International perspectives on
community care for older people. Edited by Scharf F, Wenger GC. Aldershot:
Avebury; 1995:21–38.
Woodford et al. Trials 2014, 15:157 Page 9 of 10
http://www.trialsjournal.com/content/15/1/1579. van den Heuvel ETP, de White LP, Schure LM, Sanderman R, Meyboom-de
Jong B: Risk factors for burnout in caregivers of stroke patients and
possibilities for intervention. Clin Rehabil 2001, 15:669–677.
10. Visser-Keizer C, Meyboom-de Jong B, Deelman G, Berg J, Gerritsen JJ:
Subjective changes in emotion, cognition and behaviour after stroke:
factors affecting the perception of patients and partners. J Clin Exp
Neuropsychol 2002, 24:1032–1045.
11. Berg A, Palomäki H, Lönnqvist J, Lehtihalmes M, Kaste M: Depression
among caregivers of stroke survivors. Stroke 2005, 36:639–643.
12. Visser-Meily A, Post M, van de Port I, van Heugten C, Bos T: Psychosocial
functioning of spouses in the chronic phase after stroke: improvement
or deterioration between 1 and 3 years after stroke? Patient Educ Couns
2008, 73:153–158.
13. Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS: A
meta-analysis of cognitive behavior therapy for adult depression, alone
and in comparison to other treatments. Can J Psychiatry 2013,
58:376–385.
14. Lovell K, Richards DA, Bower P: Improving access to primary mental
health care: uncontrolled evaluation of a pilot self-help clinic. Br J Gen
Pract 2003, 53:133–135.
15. Kazdin AE, Blasé SL: Rebooting psychotherapy research and practice to
reduce the burden of mental illness. Perspect Psychol Sci 2011, 6:21–37.
16. Arksey H, Hirst M: Unpaid carers’ access to and use of primary care
services. Prim Health Care Res Dev 2005, 6:101–116.
17. Bulsara CE, Fynn N: An exploratory study of GP awareness of carer
emotional needs in Western Australia. BMC Fam Pract 2006, 7:33.
18. Greenwood N, Mackenzie A, Harris R, Fenton W, Cloud G: Perceptions of
the role of general practice and practical support measures for carers of
stroke survivors: a qualitative study. BMC Fam Pract 2011, 12:57.
19. Murray J, Young J, Forster A, Ashworth R: Developing a primary
care-based stroke model: the prevalence of longer-term problems
experienced by patients and carers. Br J Gen Pract 2003, 53:803–807.
20. Simon C, Kumar S, Kendrick T: Formal support of stroke survivors and
their informal carers in the community: a cohort study. Health Soc Care
Community 2008, 16:582–592.
21. Simon C, Kumar S, Kendrick T: Cohort study of informal carers of first-time
stroke survivors: profile of health and social changes in the first year of
caregiving. Soc Sci Med 2009, 699:404–410.
22. Bennett-Levy J, Richards DA, Farrand P: Low intensity CBT interventions: a
revolution in mental health care. In Oxford guide to low intensity CBT
interventions. Edited by Bennett-Levy J, et al. Oxford: Oxford University Press;
2011:105–111.
23. Coull G, Morris PG: The clinical effectiveness of CBT-based guided
self-help interventions for anxiety and depressive disorders: a systematic
review. Psychol Med 2011, 41:2239–2252.
24. Gellatly S, Bower P, Hennessy S, Richards DA, Gilbody S, Lovell K: What
makes self-help interventions effective in the management of depressive
symptoms? Meta-analysis and meta-regression. Psychol Med 2007,
37:1217–1228.
25. Farrand P, Woodford J: Impact of support on the effectiveness of written
cognitive behavioral self-help: a systematic review and meta-analysis of
randomized controlled trials. Clin Psychol Rev 2013, 33:182–195.
26. Lewis C, Pearce J, Bisson JI: Efficacy, cost-effectiveness and acceptability
of self-help interventions for anxiety disorders: systematic review.
Br J Psychiatry 2012, 200:15–21.
27. Cuijpers P, Donker T, van Straten A, Li J, Anderson G: Is guided self-help as
effective as face-to-face psychotherapy for depression and anxiety
disorders? A systematic review and meta-analysis of comparative
outcome studies. Psychol Med 2010, 40:1943–1957.
28. Arksey H, Wallace A, Jackson K, Golder S, Hare P, Newbronner E, Baldwin S:
Access to health care for carers: barriers and interventions. York: Social Policy
Research Unit, University of York; 2003.
29. Hind D, O’Cathain A, Cooper CL, Parry GD, Isaac CL, Rose A, Martin L,
Sharrack B: The acceptability of computerised cognitive behavioral
therapy for the treatment of depression in people with chronic physical
disease: a qualitative study of people with multiple sclerosis.
Psychol Health 2009, 25:699–712.
30. Beatty L, Lambert S: A systematic review of internet-based self-help
therapeutic interventions to improve distress and disease-control
among adults with chronic health conditions. Clin Psychol Rev 2013,
33:609–622.31. Cuijpers P, van Straten A, Andersson G: Internet-administered cognitive
behavior therapy for health problems: a systematic review. J Behav Med
2008, 31:169–177.
32. Matchan F, Rayner L, Hutton J, Monk A, Steel C, Hotopf M: Self-help
interventions for symptoms of depression, anxiety and psychological
distress in patients with physical illnesses: a systematic review and
meta-analysis. Clin Psychol Rev 2014, 34:141–157.
33. Lundh U: Family carers, 4: designing services to support family carers in
Sweden. Br J Nurs 1999, 8:787–790.
34. Pinquart M, Sörensen S: Associations of stressors and uplifts of caregiving
with caregiver burden and depressive mood: a meta-analysis. J Gerontol
B Psychol Sci Soc Sci 2003, 58:112–128.
35. Germain S, Adam S, Olivier C, Cash H, Ousset PJ, Andrieu S, Vellas B,
Meulemans T, Reynish E, Salmon E, ICTUS-EADC Network: Does cognitive
impairment influence burden in caregivers of patients with Alzheimer's
disease? J Alzheimers Dis 2009, 17:105–114.
36. Grover M, Naumann U, Mohammad-Dar L, Glennon D, Ringwood S, Eisler I,
Williams C, Treasure J, Schmidt U: A randomized controlled trial of an
Internet-based cognitive-behavioral skills package for carers of people
with anorexia nervosa. Psychol Med 2011, 41:2581–2591.
37. Grover M, Williams C, Eisler I, Fairbairn P, McCloskey C, Smith G, Treasure J,
Schmidt U: An off-line pilot evaluation of a web-based systemic
cognitive-behavioral intervention for carers of people with anorexia
nervosa. Int J Eat Disord 2011, 44:708–715.
38. Scott K, Beatty L: Feasibility study of a self-guided cognitive behaviour
therapy Internet intervention for cancer carers. Aust J Prim Health 2013,
19:270–274.
39. Kennedy A, Rogers A: Improving patient involvement in chronic disease
management: the views of patients. Patient Educ Couns 2002, 47:257–263.
40. Kennedy A, Robinson A, Rogers A: Incorporating patients’ views and
experiences of life with IBS in the development of an evidence based
self-help guidebook. Patient Educ Couns 2003, 50:303–310.
41. Nilsen ES, Myrhaug HT, Johansen M, Oliver S, Oxman AD: Methods of
consumer involvement in developing healthcare policy and research,
clinical practice guidelines and patient involvement material. Cochrane
Database Syst Rev 2006, 3, CD004563.
42. Woodford J, Farrand P: Helping relatives and carers of stroke survivors
overcome depression programme. Exeter: University of Exeter; 2013.
43. Mackenzie A, Greenwood N: Positive experiences of caregiving in stroke:
a systematic review. Disabil Rehabil 2012, 34:1413–1422.
44. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M:
Developing and evaluating complex interventions: the new medical
research council guidance. BMJ 2008, 337:a1655.
45. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, Robson R, Thabane M,
Giangregorio L, Goldsmith CH: A tutorial on pilot studies: the what, why
and how. BMC Med Res Methodol 2010, 10:1.
46. Schulz KF, Altman DG, Moher D, CONSORT Group: CONSORT 2010
statement: updated guidelines for reporting parallel group randomized
trials. BMC Med 2010, 8:18.
47. Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, Dickersin
K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleža-Jeric K, Laupacis A, Moher
D: SPIRIT 2013 explanation and elaboration: guidance for protocols of
clinical trials. BMJ 2013, 346:e7586.
48. Clark DM: Implementing NICE guidelines for the psychological treatment
of depression and anxiety disorders: the IAPT experience. Int Rev
Psychiatry 2011, 23:318–327.
49. Lewis G, Pelosi AJ, Araya R, Dunn G: Measuring psychiatric disorder in the
community: a standardised assessment for use by lay interviewers.
Psychol Med 1992, 22:465–486.
50. Kroenke K, Spitzer RL, Williams JBW: The PHQ-9: validity of a brief
depression severity measure. J Gen Intern Med 2001, 16:606–613.
51. Whitebird RR, Kreitzer MJ, Lewis BA, Hanson LR, Crain AL, Enstad CJ, Mehta
A: Recruiting and retaining family caregivers to a randomized controlled
trial on mindfulness-based stress reduction. Contemp Clin Trials 2011,
32:654–661.
52. Kuyken W, Byford S, Byng R, Dalgleish T, Lewis G, Taylor R, Watkins ER,
Hayes R, Lanham P, Kessler D, Morant N, Evans A: Study protocol for a
randomized controlled trial comparing mindfulness-based cognitive
therapy with maintenance anti-depressant treatment in the
prevention of depressive relapse/recurrence: the PREVENT trial.
Trials 2010, 11:99.
Woodford et al. Trials 2014, 15:157 Page 10 of 10
http://www.trialsjournal.com/content/15/1/15753. Richards DA, Hill JJ, Gask L, Lovell K, Cherw-Graham C, Bower P, Cape J,
Araya R, Kesler D, Bland JM, Green C, Gilbody S, Lewis G, Manning C,
Hughes-Morley A, Barkham M: Clinical effectiveness of collaborative care
for depression in UK primary care (CADET): cluster randomized
controlled trial. BMJ 2013, 347:f4913.
54. Watkins ER, Mullan E, Wingrove J, Rimes K, Steiner H, Bathurst N, Eastman R,
Scott J: Rumination-focused cognitive-behavioral therapy for residual
depression: phase II randomized controlled trial. Br J Psychiatry 2011,
199:317–322.
55. Arain M, Campbell MJ, Cooper CL, Lancaster GA: What is a pilot or
feasibility study? a review of current practice and editorial policy.
BMC Med Res Methodol 2010, 10:67.
56. Browne RH: On the use of a pilot sample for sample size determination.
Stat Med 1995, 14:1933–1940.
57. Billingham SAM, Whitehead AL, Julious SA: An audit of sample sizes for
pilot and feasibility trials being undertaken in the United Kingdom
registered in the United Kingdom clinical research network database.
BMC Med Res Methodol 2013, 13:104.
58. Lancaster GA, Dodd S, Willamson PR: Design and analysis of pilot studies:
recommendations for good practice. J Eval Clin Pract 2004, 10:307–312.
59. Bennett-Levy J, Farrand P: Low intensity CBT models and conceptual
underpinnings. In Oxford guide to low intensity CBT interventions. Edited by
Bennett-Levy J, et al. Oxford: Oxford University Press; 2011:105–111.
60. Richards DA, Whyte M, Reach Out: National programme student materials to
support the delivery of training for psychological wellbeing practitioners
delivering low intensity interventions. 3rd edition. London: Rethink; 2011.
61. Department of Health: Improving Access to Psychological Therapies
implementation plan: national guidelines for regional delivery. London:
Department of Health; 2008.
62. Department of Health: Talking therapies: a four-year plan of action. London:
Department of Health; 2011.
63. Richards DA, Chellingsworth M, Hope R, Turpin G, Whyte M: Reach out:
national programme supervisor materials to support the delivery of training for
psychological wellbeing practitioners. London: Rethink; 2011.
64. Turpin G, Wheeler S: IAPT supervision guidance. London: Department of
Health; 2011.
65. Department of Health: The IAPT data handbook. London: Department of
Health; 2011.
66. Spitzer RL, Kroenke K, Williams JBW, Löwe B: A brief measure for assessing
generalized anxiety disorder: The GAD-7. Arch Intern Med 2006,
166:1092–1097.
67. Mundt C, Marks IM, Shear K, Greist JM: The work and social adjustment
scale: a simple measure of impairment in functioning. Br J Psychiatry
2002, 180:461–464.
68. Mahoney FI, Barthel DW: Functional evaluation: the barthel index. Md Med
1965, 14:61–65.
69. Knapp P, Hewison J: Disagreement in patient and carer assessment of
functional abilities after stroke. Stroke 1999, 30:934–938.
70. Holbrook M, Skilbeck CE: An activities index for use with stroke patients.
Age Ageing 1983, 12:166–170.
71. Tooth LR, McKenna KT, Smith M: Further evidence for the agreement
between patients with stroke and their proxies on the Frenchay
activities index. Clin Rehabil 2003, 17:656–665.
72. Chen M-H, Hsieh C-L, Mao H-F, Huang S-L: Differences between patient
and proxy reports in the assessment of disability after stroke. Clin Rehabil
2007, 21:351–356.
73. Elmstahl S, Malmberg B, Annerstedt L: Caregiver’s burden of patients 3
years after stroke assessed by a novel caregiver burden scale. Arch Phys
Med Rehabil 1996, 77:177–182.
74. Ware JE, Sherbourne CD: The MOS 26-item short-form health survey (SF-36).
I. Conceptual framework and item selection. Med Care 1992, 30:473–483.
75. Brooks R: EuroQol: the current state of play. Health Policy 1996, 37:53–72.
76. Chisholm D, Knapp MRJ, Knudsen HC, Amaddeo F, Gaite L, van Wijngaarden
B: Client socio-demographic and service receipt inventory–European
version: development of an instrument for international research.
EPSILON Study 5. European psychiatric services: inputs linked to
outcome domains and needs. Br J Psychiatry Suppl 2000, 39:s28–s33.
77. Patel A, Knapp M, Evans A, Perez I, Kalra L: Training care givers of stroke
patients: economic evaluation. BMJ 2004, 328:1102–1104.
78. Brazier JE, Roberts J, Deverill M: The estimation of a preference-based
measure of health from the SF-36. J Med Econ 2002, 21:271–292.79. Brazier JE, Roberts J, Tsuchiya A, Busschbach J: A comparison of the EQ-5D
and SF-6D across seven patient groups. Health Econ 2004, 13:873–884.
80. Gerhards SA, Huibers MJ, Theunissen KA, de Graaf LE, Widdershoven GA,
Evers SM: The responsiveness of quality of life utilities to change in
depression: a comparison of instruments (SF-6D, EQ-5D, and DFD).
Value Health 2011, 14:732–739.
81. Pope C, Ziebland S, Mays N: Analysing qualitative data. BMJ 2000,
320:114–116.
82. Lietz CA, Langer CL, Furman R: Establishing trustworthiness in qualitative
research in social work. Implications from a study regarding spirituality.
Qual Soc Work 2006, 5:441–458.
doi:10.1186/1745-6215-15-157
Cite this article as: Woodford et al.: Supported cognitive-behavioural
self-help versus treatment-as-usual for depressed informal carers of
stroke survivors (CEDArS): study protocol for a feasibility randomized
controlled trial. Trials 2014 15:157.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
